🇺🇸 FDA
Patent

US 11185551

Peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response

granted A61KA61K31/4188A61K31/5517

Quick answer

US patent 11185551 (Peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response) held by Caventure Drug Discovery, Inc. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Caventure Drug Discovery, Inc.
Grant date
Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4188, A61K31/5517, A61P, A61P29/00